x
ServiziMenu principaleHome
Home > Programme > Programme
Print

Programme

 

THURSDAY, 4 NOVEMBER 2021

9:00 - 10:30
Audit. II

Patient advocacy session

9:00 - 10:30
Audit. I

Sponsored satellite symposium

10:30-11:00

Coffee break

11:00-12:30
Audit. II

Patient advocacy session

11:00-12:30
Audit. I

Sponsored satellite symposium

12:30-13:30

Lunch

13:30-14:50
Audit. I

Opening session
Chairs: Fatima Cardoso, PT and Larry Norton, US

  • Opening and welcome to a new era of ABC
    Fatima Cardoso, PT
  • Opening lecture
    Stella Kyriakides, European Commissioner for Health and Food Safety, BE
  • Keynote lecture
    TBC

14:30-14.50
Audit. I

ABC Award and lecture
TBC

14:50-16:00
Audit. I

Challenges on evaluating patients with ABC
Chairs: Frédéric E. Lecouvert, BE and Christoph Thomssen, DE

  • Re-defining progressive disease: oligo-progression, pseudo-progression, endcorine flare
    Karen Gelmon, CA
  • How to act in discordant biomarker results (primary vs mets vs other mets)
    Aleix Prat, ES
  • Optimal timing and interval of imaging for ABC (clinical practice & trials)
    George W. Sledge, US
  • Is it time to change the follow-up guidelines for early BC - aka - is it worthwhile to detect metastatic disease earlier?
    Eric P. Winer, US
  • Panel discussion
    All speakers

16:00-16:20

Coffee break

16:20-16:55
Audit. I

Best abstract presentations
Chairs: Alberto Costa, IT/CH and Renate Haidinger, DE

16:55-17:55
Audit. I

The standards in 2021 
Chairs: Bertha Aguilar, MX and Elżbieta Senkus, PL

  • Current standard of care for HER2+ ABC
    Sandra M. Swain, US
  • Current standard of care for Triple Negative ABC
    Giuseppe Curigliano, IT
  • Current standard of care for ER+/HER2 neg ABC
    Nadia Harbeck, DE
  • Panel discussion
    Chairs: All speakers

18:00-19:30
Audit. II

Patient advocacy session

18:00-19:30
Audit. I

Sponsored satellite symposium

19:30

Welcome cocktail  

 

FRIDAY, 5 NOVEMBER 2021

8:30-9:40
Audit. I

Biology medley
Chair: William J. Gradishar, US and Sung-Bae Kim, KR

  • Beyond overexpression/amplification of HER2
    Giuseppe Viale, IT
  • Predictive biomarkers for immune-checkpoint inhibitors: lost or found? 
    Frédérique Penault-Llorca, FR
  • Biomarkers of resistance/response to endocrine-based therapy. What's ready for clinical practice?
    Nicholas Turner, UK
  • Hereditary breast cancer: which markers besides gBRCA?
    Shani Paluch-Shimon, IL
  • Panel discussion
    All speakers

9:40-10:35
Audit. I

Who's caring for the carers?
Chairs: Lesley Fallowfield UK, Olivia Pagani CH, and Barbara Wilson, UK

  • Spouses, children, parents: psychological issues
    Luzia Travado, PT
  • What do carers need to care
    Theresa Wiseman, UK
  • Health Care Providers: Compassionate fatigue
    Michal Braun, IL
  • Panel discussion
    Chairs and speakers

10:35-11:00

Coffee break

11:00-12:10
Audit. I

What's new in the management of inoperable inflammatory (IBC) and locally advanced breast cancer (LABC) 
Chairs: Ginny Mason, US and Daniel A. Vorobiof, US

  • Have we improved our knowledge about biology?
    Sofia D. Merajver, US
  • Systemic management of inoperable inflammatory breast cancer: any news?
    Hamouda Boussen, TN
  • Optimal loco-regional management
    Maria Joao Cardoso, PT
  • What should be updated in the ABC guidelines for systemic therapy for inoperable LABC and IBC?
    Joseph Gligorov, FR
  • Panel discussion
    All speakers

12:20-13:30

Lunch and poster session

13:30-14:40
Audit. I

From manageable to tolerable: focus on side effects 
Chairs: Shinji Ohno, JP and Eva Schumacher, DE

  • Pneumonitis/interstitial Lung Disease (ILD)
    Hope S. Rugo, US
  • Immune-related toxicity
    Carlos H. Barrios, BR
  • Preventing and treating cardiotoxicity
    Evandro de Azambuja, BE
  • The role of cannabis for ABC patients
    Matti S. Aapro, CH
  • Panel discussion
    All speakers

14:40-15:35
Audit. I

Oligometastatic disease and specific sites of metástases
Chairs: Bella Kaufman, IL and Ranjit Kaur, MY

  • Re-defining oligo-metastatic disease and its systemic management
    Prudence A. Francis, AU
  • SBRT and new radiotherapy techniques for metastatic disease
    Birgitte V. Offersen, DK
  • Optimal management of peritoneal carcinomatosis and ascites
    Nagi El Saghir, LB
  • Panel discussion
    All speakers

15:40-16:00

Coffee break

16:00-17:00
Audit. I

Drug development for ABC
Chairs: Jonas Bergh, SE and Kirsten Pilatti, AU

  • Antibody-drug conjugates: delivering chemotherapy at the tumor's doorsteps
    Javier Cortés, ES
  • Newer therapeutic options for triple negative ABC
    Rebecca A. Dent, SG
  • New drug interactions and consequences
    Alessandra Gennari, IT
  • Is the maximum tolerated dose (MDT) still the optimal goal for cancer drugs?
    Larry Norton, US
  • Panel discussion
    All speakers

17:00-18:00
Audit. I

Managing ABC during a pandemic
Chairs: Elizabeth Bergsten-Nordström, SE and Binghe Xu, CN

  • Lessons learned from COVID-19
    Laura Biganzoli, IT
  • Should all vaccines be administered to ABC patients?
    Alexandru Eniu, CH
  • Strengths and limitations of tele-medicine for ABC patients
    Fran Boyle, AU
  • Panel discussion
    All speakers

18:00-19:30
Audit. II

Patient advocacy session

18:00-19:30
Audit. I

Sponsored satellite symposium

 

SATURDAY, 6 NOVEMBER 2021

8:30-10:30
Audit. I

Consensus session (part I)
ABC6 chairs, Scientific Committee Members and Panellists

10:30-11:00

Coffee break

11:00-11:15
Audit. II

Report from ABC Patient Advocacy Committee
Ginny Mason, US

11:15-12:45
Audit. I

Consensus session (part II)
ABC6 chairs, Scientific Committee Members and Panellists

12:45-13:00
Audit. I

Close

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Please be informed that the ABC Global Alliance will hold its yearly meeting immediately after ABC6 on 6-7 November 2021. More information here

A/V RECORDING DURING THE CONFERENCE IS PROHIBITED